Cargando…

Efficient marmoset genome engineering by autologous embryo transfer and CRISPR/Cas9 technology

Genetic engineering of non-human primates, which are most closely related to humans, has been expected to generate ideal animal models for human genetic diseases. The common marmoset (Callithrix jacchus) is a non-human primate species adequate for the production of genetically modified animals becau...

Descripción completa

Detalles Bibliográficos
Autores principales: Abe, Yukiko, Nakao, Harumi, Goto, Motoki, Tamano, Moe, Koebis, Michinori, Nakao, Kazuki, Aiba, Atsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511084/
https://www.ncbi.nlm.nih.gov/pubmed/34642413
http://dx.doi.org/10.1038/s41598-021-99656-4
_version_ 1784582706598772736
author Abe, Yukiko
Nakao, Harumi
Goto, Motoki
Tamano, Moe
Koebis, Michinori
Nakao, Kazuki
Aiba, Atsu
author_facet Abe, Yukiko
Nakao, Harumi
Goto, Motoki
Tamano, Moe
Koebis, Michinori
Nakao, Kazuki
Aiba, Atsu
author_sort Abe, Yukiko
collection PubMed
description Genetic engineering of non-human primates, which are most closely related to humans, has been expected to generate ideal animal models for human genetic diseases. The common marmoset (Callithrix jacchus) is a non-human primate species adequate for the production of genetically modified animals because of their small body size and high reproductive capacity. Autologous embryo transfer (AET) is routinely utilized in assisted reproductive technologies for humans but not for experimental animals. This study has developed a novel method for efficiently producing mutant marmosets using AET and CRISPR/Cas9 systems. The embryos were recovered from oviducts of naturally mated females, injected with Cas9/guide RNA, and transferred into the oviducts of the donors. This AET method can reduce the time for in vitro culture of embryos to less than 30 min. This method uses an embryo donor as the recipient, thus reducing the number of animals and allowing for “Reduction” in the 3R principles of humane experimental technique. Furthermore, this method can utilize nulliparous females as well as parous females. We applied our novel method and generated the 6 marmosets carrying mutations in the fragile X mental retardation 1 (FMR1) gene using only 18 females including 14 nulliparous females.
format Online
Article
Text
id pubmed-8511084
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-85110842021-10-14 Efficient marmoset genome engineering by autologous embryo transfer and CRISPR/Cas9 technology Abe, Yukiko Nakao, Harumi Goto, Motoki Tamano, Moe Koebis, Michinori Nakao, Kazuki Aiba, Atsu Sci Rep Article Genetic engineering of non-human primates, which are most closely related to humans, has been expected to generate ideal animal models for human genetic diseases. The common marmoset (Callithrix jacchus) is a non-human primate species adequate for the production of genetically modified animals because of their small body size and high reproductive capacity. Autologous embryo transfer (AET) is routinely utilized in assisted reproductive technologies for humans but not for experimental animals. This study has developed a novel method for efficiently producing mutant marmosets using AET and CRISPR/Cas9 systems. The embryos were recovered from oviducts of naturally mated females, injected with Cas9/guide RNA, and transferred into the oviducts of the donors. This AET method can reduce the time for in vitro culture of embryos to less than 30 min. This method uses an embryo donor as the recipient, thus reducing the number of animals and allowing for “Reduction” in the 3R principles of humane experimental technique. Furthermore, this method can utilize nulliparous females as well as parous females. We applied our novel method and generated the 6 marmosets carrying mutations in the fragile X mental retardation 1 (FMR1) gene using only 18 females including 14 nulliparous females. Nature Publishing Group UK 2021-10-12 /pmc/articles/PMC8511084/ /pubmed/34642413 http://dx.doi.org/10.1038/s41598-021-99656-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Abe, Yukiko
Nakao, Harumi
Goto, Motoki
Tamano, Moe
Koebis, Michinori
Nakao, Kazuki
Aiba, Atsu
Efficient marmoset genome engineering by autologous embryo transfer and CRISPR/Cas9 technology
title Efficient marmoset genome engineering by autologous embryo transfer and CRISPR/Cas9 technology
title_full Efficient marmoset genome engineering by autologous embryo transfer and CRISPR/Cas9 technology
title_fullStr Efficient marmoset genome engineering by autologous embryo transfer and CRISPR/Cas9 technology
title_full_unstemmed Efficient marmoset genome engineering by autologous embryo transfer and CRISPR/Cas9 technology
title_short Efficient marmoset genome engineering by autologous embryo transfer and CRISPR/Cas9 technology
title_sort efficient marmoset genome engineering by autologous embryo transfer and crispr/cas9 technology
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511084/
https://www.ncbi.nlm.nih.gov/pubmed/34642413
http://dx.doi.org/10.1038/s41598-021-99656-4
work_keys_str_mv AT abeyukiko efficientmarmosetgenomeengineeringbyautologousembryotransferandcrisprcas9technology
AT nakaoharumi efficientmarmosetgenomeengineeringbyautologousembryotransferandcrisprcas9technology
AT gotomotoki efficientmarmosetgenomeengineeringbyautologousembryotransferandcrisprcas9technology
AT tamanomoe efficientmarmosetgenomeengineeringbyautologousembryotransferandcrisprcas9technology
AT koebismichinori efficientmarmosetgenomeengineeringbyautologousembryotransferandcrisprcas9technology
AT nakaokazuki efficientmarmosetgenomeengineeringbyautologousembryotransferandcrisprcas9technology
AT aibaatsu efficientmarmosetgenomeengineeringbyautologousembryotransferandcrisprcas9technology